Dennis Podlesak

SNDX

Dennis Podlesak serves as Director at Syndax Pharmaceuticals, Inc. (SNDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$875.1K

Net Position

Net Seller

$875.1K

Companies Traded

SNDX

Active Period

Aug 2025

1 total trades

Most Recent

Sell SNDX

Aug 14, 2025 · $875.1K

Dennis Podlesak's Insider Trading at Syndax Pharmaceuticals, Inc. (SNDX)

Buys

0 · $0.00

Sells

1 · $875.1K

Total Shares Bought

Total Shares Sold

57,600

SNDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 14, 2025↗	Sell	57,600	$15.19	$875.1K	0

Related Insiders

Keith A. Goldan

Chief Financial Officer

SNDXSell · Feb 9, 2026

Michael A Metzger

Chief Executive Officer

SNDXSell · Feb 9, 2026

Keith A. Goldan

officer: Chief Financial Officer

SNDXSell · Feb 9, 2026

Michael A Metzger

director, officer: Chief Executive Officer

SNDXSell · Feb 9, 2026

Martin H. Huber Jr.

Director

SNDXBuy · May 19, 2025

Keith Katkin

Director

SNDXBuy · May 19, 2025

Nicholas A.J. Botwood

Head of R&D, CMO

SNDXBuy · May 16, 2025

Explore More Insider Trading Data

SNDX Insider Trading Activity

View all insider trades at Syndax Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity